These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38025154)

  • 21. Andersen-Tawil syndrome: Clinical presentation and predictors of symptomatic arrhythmias - Possible role of polymorphisms K897T in KCNH2 and H558R in SCN5A gene.
    Krych M; Biernacka EK; Ponińska J; Kukla P; Filipecki A; Gajda R; Hasdemir C; Antzelevitch C; Kosiec A; Szperl M; Płoski R; Trusz-Gluza M; Mizia-Stec K; Hoffman P
    J Cardiol; 2017 Nov; 70(5):504-510. PubMed ID: 28336205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of the intravenous flecainide challenge test before oral flecainide treatment in a patient with Andersen-Tawil syndrome.
    Sato A; Takano T; Chinushi M; Minamino T
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31311787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different responses to exercise between Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia.
    Inoue YY; Aiba T; Kawata H; Sakaguchi T; Mitsuma W; Morita H; Noda T; Takaki H; Toyohara K; Kanaya Y; Itoi T; Mitsuhashi T; Sumitomo N; Cho Y; Yasuda S; Kamakura S; Kusano K; Miyamoto Y; Horie M; Shimizu W
    Europace; 2018 Oct; 20(10):1675-1682. PubMed ID: 29309601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy].
    Sarubbi B; Ducceschi V; Briglia N; Esposito R; Mayer MS; Scialdone A; Santangelo L; Iacono A
    Cardiologia; 1996 Jul; 41(7):645-51. PubMed ID: 8983831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral verapamil effectively suppressed complex ventricular arrhythmias and unmasked U waves in a patient with Andersen-Tawil syndrome.
    Erdogan O; Aksoy A; Turgut N; Durusoy E; Samsa M; Altun A
    J Electrocardiol; 2008; 41(4):325-8. PubMed ID: 18353348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compared effects of sotalol, flecainide and propafenone on ventricular repolarization in patients free of underlying structural heart disease.
    Sarubbi B; Ducceschi V; Briglia N; Mayer MS; Santangelo L; Iacono A
    Int J Cardiol; 1998 Sep; 66(2):157-64. PubMed ID: 9829329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Andersen-Tawil syndrome.
    Smith AH; Fish FA; Kannankeril PJ
    Indian Pacing Electrophysiol J; 2006 Jan; 6(1):32-43. PubMed ID: 16943893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flecainide Reduces Ventricular Arrhythmias in Patients With Genotype RyR2-positive Catecholaminergic Polymorphic Ventricular Tachycardia.
    Wangüemert Pérez F; Hernández Afonso JS; Groba Marco MDV; Caballero Dorta E; Álvarez Acosta L; Campuzano Larrea O; Pérez G; Brugada Terradellas J; Brugada Terradellas R
    Rev Esp Cardiol (Engl Ed); 2018 Mar; 71(3):185-191. PubMed ID: 28789916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of arrhythmia with β-blocker and flecainide combination in pregnant patients with Andersen-Tawil syndrome: A case report and literature review.
    Rujirachun P; Junyavoraluk A; Pithukpakorn M; Suktitipat B; Winijkul A
    Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12798. PubMed ID: 32959505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation.
    Delannoy E; Sacher F; Maury P; Mabo P; Mansourati J; Magnin I; Camous JP; Tournant G; Rendu E; Kyndt F; Haïssaguerre M; Bézieau S; Guyomarch B; Le Marec H; Fressart V; Denjoy I; Probst V
    Europace; 2013 Dec; 15(12):1805-11. PubMed ID: 23867365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response to flecainide test in Andersen-Tawil syndrome with incessant ventricular tachycardia.
    Fernández M; Marín MDR; Fernández-Armenta J; Mora-López F; Fernández Rivero R; Berruezo A; Cano Calabria L; Vázquez García R
    Pacing Clin Electrophysiol; 2018 Apr; 41(4):429-432. PubMed ID: 29023786
    [No Abstract]   [Full Text] [Related]  

  • 32. Andersen-Tawil syndrome associated with aborted sudden cardiac death: atrial pacing was effective for ventricular arrhythmias.
    Kuramoto Y; Furukawa Y; Yamada T; Okuyama Y; Fukunami M
    Am J Med Sci; 2012 Sep; 344(3):248-50. PubMed ID: 22739561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.
    Weissenburger J; Davy JM; Chézalviel F; Ertzbischoff O; Poirier JM; Engel F; Lainée P; Penin E; Motté G; Cheymol G
    J Pharmacol Exp Ther; 1991 Nov; 259(2):871-83. PubMed ID: 1941633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A peculiar case of palpitations and syncope.
    Cheung CC; Scheinman M; Lee BK
    Heart Rhythm; 2022 Mar; 19(3):505-507. PubMed ID: 35227417
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial.
    Kannankeril PJ; Moore JP; Cerrone M; Priori SG; Kertesz NJ; Ro PS; Batra AS; Kaufman ES; Fairbrother DL; Saarel EV; Etheridge SP; Kanter RJ; Carboni MP; Dzurik MV; Fountain D; Chen H; Ely EW; Roden DM; Knollmann BC
    JAMA Cardiol; 2017 Jul; 2(7):759-766. PubMed ID: 28492868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene.
    Nof E; Belhassen B; Arad M; Bhuiyan ZA; Antzelevitch C; Rosso R; Fogelman R; Luria D; El-Ani D; Mannens MM; Viskin S; Eldar M; Wilde AA; Glikson M
    Heart Rhythm; 2011 Oct; 8(10):1546-52. PubMed ID: 21699856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Andersen-Tawil syndrome. Efficacy of class IC drugs].
    Makarov LM; Komoliatova VN; Kolosov VO; Fedina NN; Solokhin IuA
    Kardiologiia; 2013; 53(1):91-6. PubMed ID: 23548357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effective dose of flecainide for arrhythmia in children].
    Sumitomo N; Ushinohama H; Hara M; Otuka M; Harada K; Okuni M
    Kokyu To Junkan; 1993 Nov; 41(11):1079-82. PubMed ID: 8256048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catheter ablation of frequent monomorphic ventricular arrhythmias in Andersen-Tawil syndrome: case report and focused literature review.
    Keegan R; Onetto L; Gregorietti F; Urruti R; Di Biase L
    J Interv Card Electrophysiol; 2023 Apr; 66(3):729-736. PubMed ID: 34665385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.